Skip to main content
Below is a list of successful whistleblower cases, some of which resulted in significant qui tam whistleblower awards under the False Claims Act and other statutes. These cases are a global list of settlements and judgments under various whistleblower statutes and amongst some of the best qui tam law firms in the country, including, but not limited to Brown, LLC. Past results don’t guarantee future success and your case will depend on your particular facts and circumstances.
By their very nature some qui tam cases are confidential and the actual whistleblower reward is not disclosed. In those cases the whistleblower award will be imputed using the maximum possible award and sometimes an average award or a whistleblower award range.
$16,650,000,000
$16.65 Billion False Claims Act Whistleblower Settlement. Banking Fraud. August 21, 2014. District of New Jersey.
Bank of America (BoA) reached a $16.65 billion settlement to resolve allegations that it failed to disclose key facts about its residential mortgage-backed securities, leading to massive losses for investors and homeowners. $1 billion from the settlement was paid pursuant to the False Claims Act in relation to BoA’s origination and sale of defective residential mortgage loans.
The three whistleblowers who filed qui tam lawsuits were eligible for up to $250 million in whistleblower awards.
$3,000,000,000
$3 Billion False Claims Act Settlement. Pharmaceutical Fraud. July 2, 2012. District of Massachusetts.
Global pharmaceutical titan GlaxoSmithKline LLC (GSK) pled guilty and agreed to pay $3 billion to resolve False Claims Act allegations that it unlawfully promoted prescription drugs, failed to report safety data, and engaged in false price reporting. $2 billion of this payment consists of GSK’s civil liability to the federal government under the False Claims Act, as well as to multiple states. It was alleged that GSK promoted drugs for unapproved, non-covered uses through issuing misleading claims. The federal government also alleged that GSK paid kickbacks to providers to induce the prescription of certain drugs.
Whistleblowers under the False Claims Act were entitled to whistleblower rewards up to $600 million.
$2,300,000,000
$2.3 Billion Healthcare Fraud Settlement – False Claims Act. Pharmaceutical Fraud. September 2, 2009. District of Massachusetts. Eastern District of Pennsylvania. Eastern District of Kentucky.
Pharmaceutical giant Pfizer Inc. and its subsidiary paid $2.3 billion to resolve liability from its illegal promotion of pharmaceutical products, including off-label promotions and kickbacks to induce prescriptions. Pfizer misbranded and promoted drugs for unapproved uses and dosages that the FDA specifically declined to approve due to safety concerns. Pfizer paid $1 billion to resolve allegations under the False Claims Act.
Six whistleblowers who filed lawsuits in three jurisdictions received more than $102 million in whistleblower awards.
$2,200,000,000
$2.2 Billion False Claims Act Settlement. November 4, 2013. Eastern District of Pennsylvania. District of Massachusetts. Northern District of California.
Pharmaceutical powerhouse Johnson & Johnson (J&J) paid more than $2.2 billion to resolve claims that it promoted prescription drugs for off-label use, and paid kickbacks to physicians and a long-term care pharmacy. $1.72 billion of this payment is allocated to civil settlements under the False Claims Act and state analogues. Multiple groups of whistleblowers received whistleblower rewards.
The whistleblowers in the Eastern District of Pennsylvania received a $112 million whistleblower award; those from the District of Massachusetts received $27.7 million in False Claims Act whistleblower rewards; and the whistleblower in the Northern District of California received a $28 million whistleblower award.
$900,000,000
$900 Million False Claims Act Settlement. October 4, 2020. U.S. District Court for the District of Massachusetts.
Record- setting non-intervened whistleblower settlement under the False Claims Act alleging that Biogen engaged in anti-kickback violations to induce physicians to prescribe its pharmaceutical products by giving fees and benefits to doctors.
False Claims Act Whistleblower Award of up to 30%, or up to $270 million.
$900,000,000
$900 Million False Claims Act Settlement. June 29, 2006. Central District of California; Northern District of Alabama; Eastern District of Louisiana; Eastern District of Missouri; Eastern District of Pennsylvania; and Western District of Tennessee.
One of the largest False Claims Act settlement to date (that was non-pharmaceutical), Tenet Healthcare, one of the nation’s largest health care chains, settled Medicare Fraud and Medicaid Fraud allegations regarding inflated health care charges, billing for services not rendered, upcoding, and kickbacks.
Under the False Claims Act the whistleblower award was up to 25%, or $225 million.
See: https://www.justice.gov/archive/opa/pr/2006/June/06_civ_406.html
$875,000,000
$875 Million Pharmaceutical False Claims Act Settlement. October 3, 2001. District of Columbia. District of Massachusetts.
TAP Pharmaceutical Products Inc. agreed to pay $875 million to resolve criminal and civil liabilities stemming from its fraudulent drug pricing and marketing scheme. TAP was accused of violating the “best price” rule and providing kickbacks to physicians and other customers to induce prescriptions. TAP paid $559 million in civil penalties to resolve its liability under the False Claims Act.
The two whistleblowers who filed qui tam lawsuits received approximately $95 million in awards.
See: https://www.justice.gov/archive/opa/pr/2001/October/513civ.htm
$745,000,000
$745 Million False Claims Act Settlement. December 2000. Northern District of Columbia.
Defendants: HCA -The Health Care Company
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$650,000,000
$650 Million Pharmaceutical False Claims Act Settlement. January 2008. Eastern District of Pennsylvania, Eastern District of Louisiana.
Drug manufacturer Merck paid $650 million dollars to resolve allegations that it engaged in kickbacks to induce prescriptions and further violated the “best prices” rule. The pharmaceutical “best prices” rule under the Medicaid Rebate Statute provides that the government is entitled to the same discounted pricing that other purchasers enjoy. The government rejected Merck’s defense that the pricing discounts were “nominal.” Merck allegedly sent kickbacks to physicians and other providers in the form of payments for “training,” “market research,” or “consultation, when in fact at best superficial work was done. The government alleged that Merck used these fake assignments and associated titles to funnel money to providers to induce prescriptions in violation of the Ant-Kickback Statute (AKS) provisions of the False Claims act.
The total eligible False Claims Act Whistleblower Award was $130 million. In fact, one whistleblower received $44.69 million from the federal share of the settlement amount and an additional $23.5 million from the states’ whistleblower recoveries. The other whistleblower was eligible for a comparable amount that may have been discounted due to the first-to-file rule.
$642,000,000
$642 Million Pharmaceutical False Claims Act Settlement – July, 1 2020. Southern District of New York. District of Massachusetts.
Pharmaceutical company Novartis has agreed to pay $642 million to settle allegations of company covering co-payments for patients using Gilenya (a drug used for treatment of relapsing forms of multiple sclerosis) and then transitioning them to Medicare so that Novartis would obtain revenue from Medicare when those patients filled prescriptions for Gilenya. Paying co-payments for patients is considered a kickback under the Anti-Kickback Statute (AKS). The company is also accused of providing illegal kickbacks to physicians in exchange for prescribing Novartis drugs.
Under the False Claims Act, since the government intervened the whistleblower was eligible for a whistleblower reward up to $128 million dollars, which is 25% of the recovery.
$631,000,000
$631 Million False Claims Act Settlement. June 26, 2003. District of Columbia.
HCA Inc., a major hospital chain, paid a $631 million settlement to resolve allegations that it defrauded Medicare, Medicaid, and TRICARE through false cost reports, kickbacks in exchange for patient referrals, and billing for unallowable costs in violation of the False Claims Act and the Anti-Kickback Statute (AKS) provisions.
The False Claims Act whistleblowers received a combined $151 million in whistleblower rewards.
See: https://www.justice.gov/archive/opa/pr/2003/June/03_civ_386.htm
$614,000,000
$614 Million Mortgage Loan Settlement under the False Claims Act – Bank Fraud. February 4, 2014. Southern District of New York.
JP Morgan Chase paid $614 million to resolve claims that it improperly approved thousands of Federal Housing Administration and Veterans Affairs loans that were not eligible under FHA and VA criteria due to failing to meet applicable agency underwriting requirements, and thus violating the False Claims Act. The false certifications of underwriting requirements caused the FHA and VA to sustain substantial losses when the unqualified loans failed.
The private whistleblower who filed the qui tam lawsuit was eligible for up to a $153 million whistleblower award.
$513,000,000
$513 Million False Claims Act Settlement. October 2016. U.S. ex rel. Williams v. Health Management Associates Inc., No. 3:09-cv-00130 (M.D. Ga.) and U.S. v. Atlanta Medical Center, Inc. No. 16-cr-00350 (N.D. Ga). Middle District of Georgia, Northern District of Georgia.
Almost a decade later after Tenet Healthcare’s $900 million Medicare and Medicaid fraud settlement, Tenet added another $513 million-dollar False Claims Act Settlement for allegedly setting up sham companies to funnel Medicare patients to its coffers in violation of the Anti-Kickback Statute (AKS).
The whistleblower whose efforts led to this settlement was eligible for a whistleblower award of up to $84.43 million.
$438,000,000
$438 Million False Claims Act Settlement – of $1.4 Billion Dollar Total Settlement. January 2009. Eastern District of Pennsylvania: United States ex rel. Rudolf, et al., v. Eli Lilly and Company, Civil Action No. 03-943 (E.D. Pa.); United States ex rel. Faltaous v. Eli Lilly and Company, Civil Action No. 06-2909 (E.D. Pa.); United States ex rel. Woodward v. Dr. George B. Jerusalem, et al., Civil Action No. 06-5526 (E.D. Pa.); and United States ex rel. Vicente v. Eli Lilly and Company, Civil Action No. 07-1791 (E.D. Pa.)
Drug Manufacturer Lilly Pharmaceuticals paid $1.4 Billion to address charges that it promoted Zyprexa for off-label uses. $438 million of the settlement was distributed to the federal government as a civil settlement under the False Claims Act, half a billion to a criminal fine, and $361 million went to the states that participated in the agreement.
This settlement resulted in a False Claims Act Whistleblower Reward of roughly $87.6 million on the Federal False Claims Act, plus the potential for an additional Whistleblower Award of roughly $72 million if the states’ recovery was imputed to the whistleblowers, for a total of roughly $150 million in potential whistleblower recovery.
See: https://www.justice.gov/archive/opa/pr/2009/January/09-civ-038.html
$385,000,000
$385 Million False Claims Act Settlement. Health Care Fraud. January 2000. District of Massachusetts.
Defendant: Fresenius Medical Care of North America
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$237,000,000
$237 Million False Claims Settlement. October 16, 2015. United States ex rel. Drakeford v. Tuomey Healthcare System, Inc. Case No. 3:05-cv-02858 (MBS). North Carolina.
The United States resolved a $237 million dollar False Claims Act (“FCA”) case judgment against Sumter, South Carolina-based Tuomey Healthcare System.
The jury found that Tuomey made arrangements with specialist physicians to refer their outpatient procedures to Tuomey, and, in exchange, it paid them compensation exceeding fair market value (“fmv”) violating the False Claims Act, the Stark Law and the Anti-Kickback Statute (AKS) provisions of the FCA. This compensation included part of the money received from Medicare by Tuomey.
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% whistleblower award, thus the relators were eligible for whistleblower rewards up to $71 million dollars.
$170,000,000
$170 Million False Claims Act Settlement. Health Care Fraud. February 2000. Northern District of California.
Defendant: Beverly Enterprises, Inc
Allegations: Mischarging; fabricated charges
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$114,000,000
$140 million False Claims Act Settlement- September 3rd, 2021 - United States ex rel. Rauch, et al. v. Oaktree Medical Centre, P.C., et al., No. 6:15-cv-01589-DCC (D.S.C.); United States ex rel. Mathewson v. Dr. Daniel A. McCollum, et al., No. 6:17-CV-01190-DCC (D.S.C.); and United States ex rel. Hawkins v. Pain Management Associates of the Carolinas, LLC, et al., No. 8:18-cv-02952-DCC (D.S.C.).
A group of South Carolina healthcare entities owned by chiropractor Daniel McCollum, were held accountable for $140 million judgment for violations of the Stark Law and the Anti-Kickback Statute (AKS) provisions of the False Claims Act. The qui tam law firm of Brown, LLC represented one of the whistleblowers and alleged defendants paid kickbacks to providers to refer urine drug tests, which in turn led to unnecessary drug testing, both prohibited under the False Claims Act.
The whistleblowers could share a whistleblower reward of as much as $35 million or up to 25% if the judgment is collectible.
$114,000,000
$114 Million False Claims Act Judgment – Jury Trial. May 23, 2018. District of South Carolina
The owner of a blood testing laboratory and two conspirators, were found liable for multiple violations of the Anti-Kickback Statute (AKS) provisions of the False Claims Act, for paying physicians kickbacks for ordering blood tests. After a 12-day jury trial, a judgment was entered against them for over $114 million.
This judgment was affirmed on appeal by the U.S. Court of Appeals for the Fourth Circuit and the whistleblower was entitled to up to $28 million as a whistleblower award.
$90,000,000
$90 Million False Claims Act Settlement. August 30, 2021. United States ex rel. Ormsby v. Sutter Health, et al., No. 15-CV-01062-LB (N.D. Cal.). Northern District of California.
Sutter Health, a major health care services provider based in California, paid $90 million to resolve allegations that it knowingly submitted unsupported diagnosis codes, causing inflated payments to be made from the Medicare Advantage program.
The whistleblower who filed this case could have received up to 25%, or $22.5 million, from this settlement. In addition, the whistleblower could receive additional awards from pursuing additional claims that the government did not intervene on.
$71,000,000
$71 Million False Claims Act Settlement. February 2000. Northern District of Ohio.
Defendants: Salti, Mohammed and Mahmoud
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$63,700,000
$63.7 Million False Claims Act Settlement. December 14, 2017. United States ex rel. Gallian v. DaVita Rx, LLC, No. 3:16-cv-0943-B. Northern District of Texas.
DaVita Rx LLC, a national pharmacy serving patients with severe kidney disease, will pay $63.7 Million to resolve allegations under the False Claims Act.
The allegations concerned billing of federal healthcare programs for medications of prescription that were never shipped or were returned, and non-compliance with requirements for documentation of proof of delivery, refill requests, etc. Additional allegations concerned the payment of financial inducements to Federal healthcare program beneficiaries as an incentive for them to use their product which allegedly violated the Anti-Kickback Statute (“AKS”).
The former DaVita Rx employees, filed lawsuits under the qui tam, or whistleblower, provisions of the False Claims Act, which permit private parties to sue on behalf of the government and will receive roughly $2.1 million from the federal recovery as a whistleblower reward.
$53,100,000
$53.1 Million False Claims Act Settlement. Health Care Fraud. July 2000. Middle District of Florida.
Defendants: Gambro Healthcare, Inc., et al.
Allegations: Medically unnecessary lab tests
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$45,000,000
$45 Million False Claims Act Settlement. November 1st, 2022. United States ex rel. Long v. Modernizing Med., Inc., No. 2:17-cv-179 (D. Vt.)
Florida-based healthcare technology firm Modernizing Medicine has agreed to pay $45 million dollars to resolve claims that it violated the False Claims Act rules by accepting and paying kickbacks to dermatologists. The settlement also resolved allegations that the company submitted false claims to Medicare by paying kickbacks for patient referrals in violation of the Anti-Kickback Statute (AKS).
The whistleblower who came forward and blew the whistle received a whistleblower award of approximately $9 million under the False Claims Act.
$40,000,000
$40 Million False Claims Act Settlement. September 2, 2022. District of New Jersey. District of Minnesota.
Bayer has agreed to pay $40 million to resolve alleged violations of offering kickbacks to hospitals and physicians in order to incentivize them to use the drugs Trasylol and Avelox as well as promoting these drugs for uses that were not considered reasonable or necessary in violation of the Anti-Kickback Statute (AKS). Bayer is also accused of misrepresenting the efficacy of their drug Baycol and downplaying its risks of causing rhabdomyolysis. Pharmaceutical fraud has plagued the industry with companies allegedly falsifying the approval, safety and manufacturing practices of products to induce approvals and sales.
Under the False Claims Act, the whistleblower was eligible for a whistleblower reward up to $12 million.
$31,000,000
$31 Million False Claims Act Settlement. Health Care Fraud. May 2000.
Defendant: Community Health Systems
Allegations: Upcoding
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$26,000,000
$26 Million False Claims Act Settlement. Royalties Fraud. March 2000. Eastern District of Texas.
Defendant: Conoco, Inc.
Allegations: Reverse – undervaluation of oil
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$22,900,000
$22.9 million False Claims Act Settlement - United States ex rels. Duffield et al.and Harris v. CHC Holdings, LLC, et al., No. CIV-17-826-HE (W.D. Okla.)
Brown, LLC announced a $22.9 million False Claims Act Settlement in which a home-health agency and in-home hospice care provider, Carter Healthcare, paid doctors to serve as sham “medical directors” to induce the doctors to refer their Medicare and TRICARE patients, and kept the “medical directors” onboard with various gifts and other perks. The settlement resolves these allegations, for which defendants admit no liability. The case was brought by two former Carter employees, who will receive substantial whistleblower awards.
The whistleblowers could share a whistleblower reward as much as $5.75 million or up to 25% since the government intervened in the matter.
$22,500,000
$22.5 Million False Claims Act Settlement. December 7th, 2022. United States and State of California ex rel. Bordas v. Dignity Health and Tenet Healthcare Corporation, et al. (C.D. Cal.)
Dignity Health (Dignity) has agreed to pay a total of $22.5 million to resolve allegations of False Claims Act violations related to the submission of false claims to California’s Medicaid program, Medi-Cal. The alleged false claims include providing unnecessary treatment and/or services, as well as overbilling.
The whistleblower who came forward and blew the whistle received a whistleblower reward of approximately $3.9 million under the False Claims Act.
$16,700,000
$16.7 Million False Claims Act Settlement. February 2000. Procurement Fraud.
Defendant: CRSS, Inc. and Metcalf & Eddy, Inc.
Allegations: FMS – Reimbursement for subcontractor costs before subcontractors paid
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$15,500,000
$15.5 Million False Claims Act Settlement. Procurement Fraud. August 2000. Northern District of California.
Defendant: W.R. Grace & Co. and Baker & Taylor, Inc.
Allegations: Overcharging on library books
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$13,670,000
$13.67 Million False Claims Act Settlement – Defense Contractor Fraud. June 14, 2022. Southern District of Texas.
Kellogg Brown & Root Services Inc. settled False Claims Act allegations that they rigged the contract bidding process for and received kickbacks from subcontractors for the Logistics Civil Augmentation Program (LOGCAP) III contract, under which KBR was required to provide logistics support to U.S. Army forces in Iraq. These actions violate the Anti-Kickback Statute (AKS), a provision of the False Claims Act.
A whistleblower award of up to $3.5 million was available under the False Claims Act whistleblower settlement process.
See: https://www.justice.gov/opa/pr/kbr-defendants-agree-settle-kickback-and-false-claims-allegations
$13,500,000
$13.5 Million False Claims Act Settlement. August 2000. Eastern District of New York.
Defendants: Nuveen Investments, et al.
Allegations: Yield burning
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$12,200,000
$12.2 Million False Claims Act Settlement. April 18, 2017. United States ex rel. Christopher Sean Capshaw, et al. v. Bryan K. White, et al.; Civil Action No. 3:12-cv-4457. Northern District of Texas.
International Tutoring Services, LLC, f/k/a International Tutoring Services, Inc., and d/b/a Hospice Plus; Goodwin Hospice, LLC; Phoenix Hospice, LP; Hospice Plus, L.P.; and Curo Health Services, LLC f/k/a Curo Health Services, Inc. will pay $12.2 Million to resolve allegations under the False Claims Act.
The allegations concerned illegal kickbacks paid to doctors, nurses, medical providers, etc., in exchange for patient referrals in the form of equity-free interest, sham loans, stock dividends, cash, gift cards, and other items of value, such as free rental space. Kickbacks violate the AKS (anti-kickback statute) and are illegal per se.
Under the False Claims Act, the individuals who commenced the action were eligible for a whistleblower award up to $3.66 million dollars.
See: https://www.justice.gov/usao-ndtx/pr/hospice-companies-pay-122-million-settle-kickback-claims
$12,072,848
$12 Million False Claims Act Settlement. Health Care Fraud. August 2000. Eastern District of Pennsylvania.
Defendant: University of Pennsylvania Health Systems
Allegations: Improper certification of patients whose condition was unlikely to improve
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$11,900,000
$11.9 Million False Claims Act Settlement. Royalties Fraud. April 2000. Eastern District of Texas.
Defendant: Pennz Energy
Allegations: Reverse – undervaluation of oil
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$10,900,000
$10.9 Million False Claims Act Settlement. Health Care Fraud. February 2000. Northern District of Illinois.
Defendant: University of Chicago
Allegations: Improper coding
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$10,000,000
$10 Million False Claims Act Settlement. November 20, 2019. United States ex rel. Stone v. Jewish Hosp. & St. Mary’s Healthcare, Inc., et al., Civil Action No. 3:17-294 (W.D. Ky.) Western District of Kentucky.
Jewish Hospital has agreed to pay over $10 million to settle allegations of knowingly submitting claims to Medicare for prescription drugs that failed to meet Medicare coverage requirements, including failure to obtain the treating physician’s signature on the order to establish medical necessity, failure to verify that refills were reasonable and necessary, and failure to document that the drugs were actually delivered. The hospital is also accused of violating the Anti-Kickback Statue (AKS) by submitting Medicare claims that were induced from improper payments provided to Medicare beneficiaries in the form of free blood glucose testing supplies and waiver of co-payments and deductibles for insulin.
Under the False Claims Act, the whistleblower is receiving a whistleblower award of $1.85 million.
$10,000,000
$10 Million False Claims Act Settlement. Heath Care Fraud. August 2000. Eastern District of Texas.
Defendant: Transworld Healthcare, Inc.
Allegations: Kickbacks
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$8,900,000
$8.9 Million False Claims Act Settlement. Health Care Fraud. February 2000. District of Maryland
Defendant: Connecticut General Life Ins. Co.
Allegations: Overcharging as Medicare carrier
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$5,400,000
$5.4 Million False Claims Act Settlement. Health Care Fraud. August 2000. Eastern District of Missouri
Defendant: Abbott Ambulance, Inc.
Allegations: Unnecessary transportation
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$5,200,000
$5.2 Million False Claims Act Settlement. June 2, 2022. Defendants Numet Machining Techniques, LLC (“Numet”), Numet Industries, Inc., KCO Numet, Inc., and Kidd & Company, LLC (collectively the “Numet Entities”). District of Connecticut.
Aerospace manufacturer Numet Machining Techniques settled allegations that it falsely certified itself as a small business and thereby improperly obtained small business contracts for which it was ineligible.
Although the government did not identify whether a whistleblower was involved, a whistleblower could have received a False Claims Whistleblower Award of 15-30% of the government’s recovery, or $780,0000 to $1,560,000.
$4,600,000
$4.6 Million False Claims Act Settlement. June 06, 2022. Massachusetts ex rel. Collins, et al. v. Molina Healthcare, Inc., et al. No. 3:16-cv-30177-MGM (D. Mass.) District of Massachusetts
Pathways of Massachusetts, a former Massachusetts outpatient behavioral health provider along with its parent company Molina Healthcare, Inc., will pay $4.6 million to resolve allegations under the False Claims Act.
The allegations concerned billing Medicare and Medicaid for services that were performed by unlicensed individuals and poorly supervised. For example, allegedly psychotherapy was performed without proper licensing or supervision and the government paid for the services as if it was performed by properly credentialed individuals.
The whistleblower award under the False Claims Act is up to 30% of the government’s recovery, so under the statute, the whistleblowers stand to receive whistleblower rewards up to $1.38 million dollars.
$4,500,000
$4.5 Million False Claims Act Settlement. Procurement Fraud. July 2000.
Defendant: Compaq Computer Corp.
Allegations: DOD – Inflated labor costs
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$4,250,000
$4.25 Million False Claims Act Settlement. Grant Program Fraud. April 2000. Northern District of Ohio.
Defendant: Lockheed Martin Naval Electronics & Surveillance
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$3,000,000
$3 Million False Claims Act Settlement. May 25th, 2022. U.S. ex rel. Altizer v. Heytex USA, Inc., Civil Action No. 7:20-cv-00170 (W.D.Va.). Western District of Virginia.
HEYtex USA allegedly defrauded the United States Government by knowingly selling fabrics to the military that failed to meet required specifications.
The whistleblower who reported this case received a False Claims Act Whistleblower Award of 15-30% of the government’s recovery, or $450,000 to $900,000.
$2,800,000
$2.8 Million False Claims Act Settlement. June 28, 2022. Eastern District of Texas.
Fifteen doctors in Texas agreed to pay $2.8 million to settle False Claims Act allegations that they were paid from nine management service organizations (MSOs) in exchange for ordering tests from three laboratories, in violation of the Stark Act and the Anti-Kickback Statute provisions of the False Claims Act.
A whistleblower award up to $840,000 was available for blowing the whistle.
$2,700,000
$2.7 Million False Claims Act Settlement. Royalties Fraud. June 2000. Eastern District of Texas.
Defendant: Union Pacific Resources Co.
Allegations: Reverse – undervaluation of oil
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$2,100,000
$2.1 Million False Claims Act Settlement. Health Care Fraud. February 2000.
Defendant: Medical Center at Princeton
Allegations: Billing for outpatient as inpatient
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$1,500,000
$1.5 Million False Claims Act Settlement. Health Care Fraud. July 2000.
Defendant: University of Kansas Medical Center, et al.
Allegations: Physicians not present
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$1,500,000
$1.5 Million False Claims Act Settlement. Health Care Fraud. July 2000. Southern District Texas.
Defendant: Mack, Dr. Harold
Allegations: Billing for services not performed
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$1,400,000
$1.4 Million False Claims Act Settlement. Procurement Fraud. Western District of Texas.
Defendant: Page Avjet Corp.
Allegations: FMS – Payment made for non-US (Israeli) goods
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$1,300,000
$1.3 Million False Claims Act Settlement. Health Care Fraud. March 2000.
Defendant: Eisenhower Medical Center
Allegations: Billing for MRI tests not performed
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$1,200,000
$1.2 Million False Claims Act Settlement. Health Care Fraud. July 2000
Defendant: Mercy Health Care System
Allegations: No documentation that faculty physicians were involved in treatment
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$1,162,336
$1.1 Million False Claims Act Settlement. July 2000.
Defendant: Mercy Health System of Southeastern Pennsylvania
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$1,061,392
$1 Million False Claims Act Settlement. Procurement Fraud. June 2000.
Defendant: Raytheon Co.
Allegations: Failure to test
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$800,000
$800,000 False Claims Act Settlement. Procurement Fraud. August 2000.
Defendant: Telephonics Corp.
Allegations: FMF – Contingent fees
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$800,000
$800,000 False Claims Act Settlement. Procurement Fraud. August 2000.
Defendant: Griffon Corp.
Allegations: Failure to disclose payments made to Greek representative to win Greek Navy contract
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$750,000
$750,000 False Claims Act Settlement. Procurement Fraud. March 2000. Western District of Louisiana
Defendant: Northrop Grumman Corp.
Allegations: DOD – Failure to properly treat aluminum parts
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$600,000
$600,000 False Claims Act Settlement. Health Care Fraud. February 2000.
Defendant: Charter Behavioral Health Systems, LLC
Allegations: Upcoding – psychiatric services
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$575,000
$575,000 False Claims Act Settlement. Procurement Fraud. July 2000. District of Maryland.
Defendant: Guardian Moving and Storage Co., Inc.
Allegations: Billing for non-union labor at union rates
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$359,000
$359,000 False Claims Act Settlement. Health Care Fraud.January 2000. District of Missouri.
Defendant: Columbia Regional Hospital
Allegations: Upcoding – pneumonia
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$330,000
$330,000 False Claims Act Settlement. Health Care Fraud. January 2000. Western District of Missouri.
Defendants: Truman Medical Center and Hospital Hill Health Services Corp. Inc.
Allegations: Prenatal care not provided; services not rendered by physicians.
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$320,000
$320,000 False Claims Act Settlement. Procurement Fraud. March 2000. District of Nevada.
Defendant: Maxwell-Sierra
Allegations: Improper testing of electronic components
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$309,000
$309,000 False Claims Act Settlement. Health Care Fraud. February 2000.
Defendant: University Medical Center
Allegations: Doubling billing; unbundling
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$301,000
$301,000 False Claims Act Settlement. Health Care Fraud. August 2000. District of Maryland.
Defendant: Lang, Dr. Joel
Allegations: Billing for foot care that was not reimbursable – toenail trimming
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$258,233
$258,233 False Claims Act Settlement. Postal Fraud. January 2000. District of Utah.
Defendant: Petty, Stephen K.
Allegations: Tendered checks for postage on closed accounts
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$200,000
$200,000 False Claims Act Settlement. Royalties Fraud. May 2000. Eastern District Texas.
Defendant: Sunoco Inc.
Allegations: Reverse – undervaluation of oil
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$160,000
$160,000 False Claims Act Settlement. Health Care Fraud. July 2000. Eastern District of Pennsylvania.
Defendants: Mercy Douglass Human Services Center and Mercy Douglass Center, Inc.
Allegations: Inadequate care
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$120,700
$120,700 False Claims Act Settlement. Health Care Fraud. March 2000. Southern District of Florida
Defendant: Friedman, Estate of Arnold
Allegations: Services not performed
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.
$100,000
$100,000 False Claims Act Settlement. Procurement Fraud. March 2000. Eastern District of Virginia.
Defendant: Harris Corporation
Allegations: False claims
Under the False Claims Act, whistleblowers are entitled to a whistleblower award of up to 30% of the government’s total recovery.